BioCentury
ARTICLE | Management Tracks

Scott Leffler named CFO at Myriad

Plus: Brian MacDonald retires as chief innovation officer at Disc, and updates from BioAgeis and Sofinnova Partners

December 22, 2023 2:02 AM UTC

Scott Leffler will become CFO of  Myriad Genetics Inc. (NASDAQ:MYGN) on Jan. 29 following the retirement of CFO Bryan Riggsbee, who will continue as strategic adviser until March 31. Leffler was CFO at Clover Health and Sotera Health Co. (NASDAQ:SHC). 

Brian MacDonald is retiring as chief innovation officer of  Disc Medicine Inc. (NASDAQ:IRON) and will become chair of its scientific advisory board. Disc is developing therapies for serious hematological diseases...